MacroSolve, Inc. (PINK:MCVE, MCVE message board) hasn't been performing well on the stock market lately. In the last two sessions MCVE has recorded two new 52-week lows, despite being promoted, or exactly because of it.

At the closing bell a MCVE share was worth $0.058, 14.71% less than yesterday. The volume of 334 thousand is slightly above the average.

A number of promotional newsletters disclosed a $5 thousand compensation for covering MCVE. The company hasn't had a solid financial performance, either, so the promoters focus on the potential gains from the lawsuits MCVE filed against some big companies.

While it's true that favorable outcomes of the lawsuits could result in financial gains for MCVE, it's not certain they will win in court, and even if they do, a better performance on their part would be much more valuable.

In theory, MCVE should be able to perform much better business-wise, but it seems the company is not quite there yet, and losing money is not something a business can afford to do for too long before investors give up on it.

At any rate, now MCVE is in trouble. The recent announcements about the Small Cap Conference, and the launch of the Corporate Profile mobile app. didn't do much more than bring the price of MCVE stock down. It will be interesting to see if MCVE can manage to get out of this slump.

In addition, this year may be named the year of filed suits for MCVE. The company filed suit against AT&T Inc., AT&T Mobility LLC, SalesForce.com, Inc., Dell Inc dba Dell Services, Groupon, Living Social, Inc., Citigroup Inc, Whoop, Inc.........

Thanks this was helpful. Still, what stands behind the numbers was my question. the patent for ReForm XT is an asset and all cost associated with it. So, they invested in directors' salaries or.... in what?

11.Guest

November 28, 2011, 04:38PM

The "Long Term Investments" are the costs associated with the development of ReFormXT and the other "canned" products. FASB requires that you depreciate the "investment" or offset revenue with the development expense, rather than expense those costs as you would in other environments.

Agree, financials look poor. Do you know what are the announced by MCVE long term investments?

13.Guest

November 25, 2011, 03:10PM

Revenues from any settlements will provide a one time "shot in the arm" for Macrosolve financials. Recurring revenues are what is needed here and one cannot count on Macrosolve to produce. ReFormXT is a very poor application development tool IMHO (based on 30 years of experience). The UI is clunky and the idea of having to redo reporting every time a user needs a material change to the app is astounding, but in a bad way.

IMHO Macrosolve's custom app development involves poor estimating of scope, cost over-runs and very bad customer service. Not the hallmarks of a successful company.